Indivior Pharmaceuticals, Inc. Common Stock (INDV) Financials
Key financial figures for Indivior Pharmaceuticals, Inc. Common Stock (Q4 2025).
- Revenue
- $358M
- Net Income
- $102M
- EPS
- $0.81
- Total Assets
- $1.2B
- Operating Cash Flow
- -$221M
Full income statement, balance sheet, and cash flow for Indivior Pharmaceuticals, Inc. Common Stock on SentiSense.